financetom
Business
financetom
/
Business
/
Iridium Communications Jump 10% After Q1 Results - Here's Why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Iridium Communications Jump 10% After Q1 Results - Here's Why
Apr 18, 2024 7:10 AM

Iridium Communications Inc ( IRDM ) shares are trading higher on Thursday.

The company reported first-quarter earnings per share of 16 cents, outpacing the Wallstreet estimate of 15 cents. Quarterly revenues of $203.85 million beat the analyst consensus of $193.75 million, driven by strong service revenue growth and subscriber expansion.

Total billable subscribers grew 14% year-over-year to 2.33 million, led by growth in commercial IoT.

Operational EBITDA for the first quarter was $115.0 million, as compared to $111.9 million for the prior-year period, representing a year-over-year increase of 3%. 

Net income benefitted from a year-over-year decrease in depreciation expense and continued growth in total commercial services revenue.

Quarterly sales consisted of $148.6 million of service revenue and $55.3 million of revenue related to equipment sales and engineering and support projects.

“Continued strong service revenue growth fueled Iridium’s business results in the first quarter,” said Matt Desch, CEO, Iridium. 

Desch added, “Subscriber growth and demand for Iridium’s mission-critical applications are driving new service development and free cash flow.”

What’s Next?

Iridium Communications ( IRDM ) reiterated total service revenue growth between 4% and 6% for full-year 2024. Total service revenue for 2023 was $584.5 million.

Full-year 2024 OEBITDA is reaffirmed between $460 million and $470 million. OEBITDA for 2023 was $463.1 million.

The company now expects longer-term cash tax rate will move closer to the statutory rate in 2028.

According to Benzinga Pro, IRDM stock has lost over 53% in the past year. Investors can gain exposure to the stock via ARK Space Exploration & Innovation ETF and ARK Autonomous Technology & Robotics ETF .

Read Next: Vingroup’s VinFast Faces Financial Risks Amidst Global Ambitions, With $5.7B Loss Over Past Three Years

Price Action: IRDM shares are trading higher by 10.7% to $27.37 on the last check Thursday. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lilly to launch Mounjaro pen in India to compete with Novo's Wegovy
Lilly to launch Mounjaro pen in India to compete with Novo's Wegovy
Jun 26, 2025
By Rishika Sadam HYDERABAD, June 26 (Reuters) - Eli Lilly ( LLY ) said on Thursday India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster weight-loss drug, Mounjaro, giving it more options to compete with Novo Nordisk's recently launched Wegovy. Lilly started selling Mounjaro in India in late March for diabetes and obesity, and it...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Global Medical REIT Insider Bought Shares Worth $1,042,528, According to a Recent SEC Filing
Global Medical REIT Insider Bought Shares Worth $1,042,528, According to a Recent SEC Filing
Jun 26, 2025
03:41 AM EDT, 06/26/2025 (MT Newswires) -- Mark Okey Decker Jr, Director, Chief Executive Officer and President, on June 23, 2025, executed a purchase for 160,000 shares in Global Medical REIT ( GMRE ) for $1,042,528. Following the Form 4 filing with the SEC, Decker has control over a total of 160,000 common shares of the company, with 160,000 shares...
Vera Therapeutics Insider Bought Shares Worth $5,277,311, According to a Recent SEC Filing
Vera Therapeutics Insider Bought Shares Worth $5,277,311, According to a Recent SEC Filing
Jun 26, 2025
03:43 AM EDT, 06/26/2025 (MT Newswires) -- Patrick G Enright, Director, on June 23, 2025, executed a purchase for 250,000 shares in Vera Therapeutics ( VERA ) for $5,277,311. Following the Form 4 filing with the SEC, Enright has control over a total of 3,596,593 Class A common shares of the company, with 3,596,593 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1831828/000095017025090110/xslF345X05/ownership.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved